Preethi Sundaram insider trades
Open-market stock purchases and sales by Preethi Sundaram, Chief Strategy Officer at Catalyst Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 28, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 29, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | — |
| Dec 29, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 8, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | — |
| Dec 8, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 21, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 21, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | — |
| Nov 20, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 20, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- CPRX Catalyst Pharmaceuticals, Inc: 4 sales, last Dec 29, 2025